Colonis Pharma

The pharmaceutical industry isn’t just about developing new drugs – it’s about enhancing existing ones to deliver even greater value. Value-added medicines are transforming patient care, making treatments more effective, accessible, and tailored to individual needs.    🌟 In our latest article, we dive into:    📚 The evolution and history  Uncover the origins of value-added medicines and how they are revolutionising the industry.    📊 Trends fuelling pharma growth  From digital health to personalised therapies, see what’s driving this new era of pharmaceutical innovation.    🤝 Colonis’ impact  Learn how Colonis is pushing boundaries to develop medicines that truly make a difference.    ✨ Discover how these trends are setting the stage for the next big leap in healthcare. Read the full article here:    https://lnkd.in/eZft2rMW   Let’s redefine what’s possible in medicine, together.    #PharmaEvolution #ValueAddedMedicines #HealthcareTransformation #Colonis 

At Colonis, we believe in the power of value-added medicines to transform the healthcare landscape. Our approach is simple – take what works and make it even better.    🏆 The benefits speak for themselves:    ⚕️ For HCPs: Our value-added medicines help healthcare professionals manage patient care more effectively with improved adherence and fewer complications.    ❤️ For patients: We focus on formulations that make medications easier to take, enhancing compliance and quality of life – because every patient deserves the best.    💼 For business: By adding value to existing treatments, we create unique market advantages that drive growth and make healthcare more sustainable.    At Colonis, we’re not just adding value – we’re creating it. Let’s lead the change in healthcare, one innovative solution at a time! https://lnkd.in/g5_8ixFn #ValueInValueAdded #Colonis #HealthcareInnovation #PatientFirst #BusinessGrowth 

The pharmaceutical industry is rapidly evolving, and value-added medicines are at the forefront of this transformation. From enhancing patient outcomes to driving sustainable growth, these innovations are reshaping how we think about healthcare.  📝 In our latest thought leadership article, we explore:    🔍 The definition and history of value-added medicines  Discover how these innovative treatments have evolved over the years, adding new dimensions to traditional pharmaceutical approaches.    📈 Trends driving growth  Learn about the latest market dynamics, from technological advances to shifting patient needs.    🏥 Our role in the evolution of pharma  See how we’re leading the charge with innovative products that set new standards in patient care and support.    🔗 Ready to explore the future of pharma?  Read the full article here: https://lnkd.in/eZft2rMW   Join the conversation and discover how value-added medicines are shaping the future of healthcare. Let’s evolve together! 🚀  #PharmaceuticalIndustry #ValueAddedMedicines #HealthcareInnovation #Colonis 

The pharmaceutical industry is rapidly evolving, and value-added medicines are at the forefront of this transformation. From enhancing patient outcomes to driving sustainable growth, these innovations are reshaping how we think about healthcare.  📝 In our latest thought leadership article, we explore:    🔍 The definition and history of value-added medicines  Discover how these innovative treatments have evolved over the years, adding new dimensions to traditional pharmaceutical approaches.    📈 Trends driving growth  Learn about the latest market dynamics, from technological advances to shifting patient needs.    🏥 Our role in the evolution of pharma  See how we’re leading the charge with innovative products that set new standards in patient care and support.    🔗 Ready to explore the future of pharma?  Read the full article here: https://lnkd.in/eZft2rMW   Join the conversation and discover how value-added medicines are shaping the future of healthcare. Let’s evolve together! 🚀  #PharmaceuticalIndustry #ValueAddedMedicines #HealthcareInnovation #Colonis 

We had a great time attending CPHI this week. It was amazing to see so many people and talk about potential partnerships. We're looking forward to the exciting future of value-added medicines together.    If we didn't get a chance to connect, you can get in contact with the team here: https://lnkd.in/esXEPiFQ    #CPHIMilan #CPHI 

Our Regulatory Affairs Director, Vamshee J., Alliance and Business Development Manager, Suzie Stratford, and New Product Development Manager, Narendra Patel are currently in Milan attending the annual CPHI conference. If you're there too, make sure you arrange a meeting to chat about the exciting plans we have for the future of value-added medicines. Book a conversation with us today: https://lnkd.in/esXEPiFQ #CPHIMilan #Colonis

Exciting News: Colonis joins the Medicines for Europe Value Added Medicines Group    We’re thrilled to announce that we've been accepted as a member of the Medicines for Europe Value Added Medicines Group. We’ll be joining an incredible group of industry leaders all dedicated to making healthcare accessible through high-quality, affordable medicines.    At Colonis Pharma, we share Medicines for Europe’s commitment to enhancing patient care by addressing unmet needs with value added medicines. Our innovative approach aligns perfectly with the values of Medicines for Europe, as we continue to champion better healthcare solutions for all.     Becoming a member is an incredible milestone, allowing us to contribute to and collaborate with the best in the industry. Stay tuned for more updates as we look forward to the next steps!     #Colonis #MedicinesForEurope #HealthcareInnovation #ValueAddedMedicines #Pharma 

The Colonis team are looking forward to meeting you at CPHI in Milan from the 8th until the 10th of October. Our Alliance and Business Development Manager, Suzie Stratford, will be on hand to meet with you and chat about the exciting opportunities we have in European markets. At Colonis Pharma, we're passionate about the difference value-added medicines can make to the lives of HCPs and patients. If you're attending the event, or are interested in becoming a partner, we'd love to meet with you. Book a conversation with us today: https://lnkd.in/esXEPiFQ #CPHIMilan #Colonis

The Colonis team are looking forward to meeting you at CPHI in Milan on 8 - 10 October.   There to meet with you will be Michael Dobson, Commercial Director, Suzie Stratford, Alliance and Business Development Manager and Narendra Patel, New Product Development Manager. At Colonis Pharma we understand the importance of great partnerships in creating growth in new global markets to meet unmet patient needs across the globe. If you have an in-licensing opportunity, Narendra can provide expertise on the expansion of your portfolio within the UK market. Likewise, Suzie is keen to further explore opportunities to bring our portfolio of value-added medicines to more global markets. Book a conversation with us today: https://lnkd.in/esXEPiFQ To find out more information please visit: www.colonis.co.uk   #CPHI #CPHIMilan #Pharma #Pharmaceuticals #ValueAddedMedicines

The Colonis Partner Congress 2024 is a wrap! As always it was a pleasure to catch up with the extended Colonis Pharma family, exploring further opportunities to bring our portfolio of value-added medicines to global markets. From the team at Colonis; Andrew Trouton, Michael Dobson, Suzie Stratford, Patty Efraimidou and Vamshee J. thank you Abdul Rauf Jabour, Fredrik Sjövall, Gadi Ben Nissim, Liora Shukovski Ph.D, Maarten Kamphuis, Michael Cullen, Mihaela Vuksic, DBA, Tarun Chawla and Yogesh Thombare for being an important part of creating wider accessibility to value-added medicines. Even the rain couldn't dampen the enthusiasm.